HuagongsheHuagongshe Chemistry Print Report · For research reference only
chloro-5-[3-[(methylsulfonyl)oxy]propyl]-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide → 2-Chloro-5-[3-[[2-(1H-imidazol-4-yl)ethyl]amino]propyl]-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | chloro-5-[3-[(methylsulfonyl)oxy]propyl]-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide | HCID 12988688 | — |
| Reactant | HCID 178419017 | HCID 178419017 | — |
| Product | 2-Chloro-5-[3-[[2-(1H-imidazol-4-yl)ethyl]amino]propyl]-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)benzamide | HCID 178522744 | — |
Reaction Steps
Synthesized from 2-chloro-5-[3-[(methylsulfonyl)oxy]propyl]-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide (Example 6e, 1 mg) and histamine according to the procedure described in Example 6f to afford the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07297818B2 |
| Source dataset | uspto-grants-2007_11 |
| ORD ID | ord-867e4bc466134333ae98fc4bfac6b540 |
| Source note | uspto-grants-2007_11 |